Kinnate Biopharma Inc. carries a market capitalization of 124.99M, placing it among publicly traded companies globally.
| Market Cap | 124.99M |
| Enterprise Value | N/A |
Kinnate Biopharma Inc.'s stock has declined approximately -6.85413% over the past 52 weeks. The 50-day moving average sits at 2.49, while the 200-day moving average is 2.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.85413% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 2.25 |
| Average Volume (20 Days) | N/A |